Dr. Christian Capitini has received an award of $48,942 from the UWCCC to pursue pilot studies of “Monitoring of 19F-labeled NK cell trafficking for cancer immunotherapy using MRI”. This work is developing a new way to label NK cells with a novel Fluorine isotope, that enables sensitive MRI detection.
This will potentially be of great help in monitoring the activity of NK cell immunotherapy.